Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MPI | P34949 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22412510 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL285568 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL9736991 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL129544 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL8057 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL3397672 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL9737359 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL9737508 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL2387363 | 0.98 | LMNA (0.39) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL9736985 | 0.98 | TDP1 (0.43) | LMNAL3MBTL1TDP1MPIPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3345 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137616-A1 | Skincare Composition Utilizing a Metabolomics Guided, Bioprocess Engineered Sunflower Sprout Active | JAMRM LLC (US) | 2026-05-21 | — | — | US | claimed |
| CN-122038431-A | Method for synthesizing D-psicose from glucose by modifying escherichia coli | 福州大学 | 2026-05-15 | — | — | CN | claimed |
| US-20260028612-A1 | STORAGE STABLE MICROBIAL COMPOSITION | LANBIOTIC GMBH (AT) | 2026-01-29 | — | — | US | claimed |
| EP-3924473-B1 | ENZYMATIC PRODUCTION OF MANNOSE | BONUMOSE INC (US) | 2026-01-28 | — | — | EP | claimed |
| US-12527734-B2 | Skincare composition utilizing a metabolomics guided, bioprocess engineered sunflower sprout active | JAMRM, LLC (US) | 2026-01-20 | — | — | US | claimed |
| WO-2025235319-A1 | METHODS AND COMPOSITIONS FOR PRODUCTION OF CARBOHYDRATES FROM CO2 BY A CHEMOLITHOAUTOTROPH | KIVERDI, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| EP-4587505-A1 | STORAGE STABLE MICROBIAL COMPOSITION | Lanbiotic GmbH (AT) | 2025-07-23 | — | — | EP | claimed |
| CN-120118964-A | Construction and application of escherichia coli engineering strain for synthesizing L-threonine by using ethylene glycol | 元素驱动(杭州)生物科技有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-119907824-A | Storage-stable microbial compositions | 兰生物有限公司 | 2025-04-29 | — | — | CN | claimed |
| EP-4539818-A1 | SKINCARE COMPOSITION UTILIZING A METABOLOMICS GUIDED, BIOPROCESS ENGINEERED SUNFLOWER SPROUT ACTIVE | Jamrm, LLC (US) | 2025-04-23 | — | — | EP | claimed |
| EP-0596838-A2 | Esters of L-carnitine and alkanoyl L-carnitines with glycolic acid or esters thereof and pharmaceutical compositions containing same for treating dermatoses | AVANTGARDE S.p.A. (IT) | 1994-05-11 | — | — | EP | claimed |
| EP-0591857-A1 | Use of L-carnitine and acyl L-carnitines for the long-term treatment of non-insulin-dependent diabetic patients | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1994-04-13 | — | — | EP | claimed |
| EP-0590355-A1 | Use of L-carnitine and acyl L-carnitines for treating patients suffering from aids-related syndromes and asymptomatic HIV-seropositive patients | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1994-04-06 | — | — | EP | claimed |
| EP-0282002-B1 | COMPOSITIONS OF OATS AND NETTLE EXTRACTS TO BE USED AS A FOOD ADDITIVE OR PHARMACEUTICAL PREPARATION IN HUMAN HEALTH CARE | ARCOPHARMA LTD. (CH) | 1993-08-04 | — | — | EP | claimed |
| EP-0219101-B1 | SILVER HALIDE PHOTOGRAPHIC MATERIAL | KONICA CORPORATION (JP) | 1992-12-30 | — | — | EP | claimed |
| EP-0483261-A1 | HIRUDIN PEPTIDE DERIVATIVES | BIOGEN, INC. (US) | 1992-05-06 | — | — | EP | claimed |
| WO-1991001328-A1 | HIRUDIN PEPTIDE DERIVATIVES | BIOGEN, INC. (US) | 1991-02-07 | — | — | WO | claimed |
| US-4935338-A | Silver halide photographic material containing aqueous latex having coated polymer particles | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1990-06-19 | — | — | US | claimed |
| WO-1990006128-A1 | METHODS AND COMPOSITIONS FOR INHIBITING PLATELET AGGREGATION | BIOGEN, INC. (US) | 1990-06-14 | — | — | WO | claimed |
| EP-0372670-A2 | Hirudin peptides for inhibiting platelet aggregation | BIOGEN, INC. (US) | 1990-06-13 | — | — | EP | claimed |